Charlotte Casebourne Stock

Charlotte Casebourne Stock is a seasoned entrepreneur and advisor in the biotechnology sector, co-founding Theolytics in 2017, where successful fundraising of $45M has facilitated the development of innovative biologics for ovarian cancer treatment. As a Board Member of the BioIndustry Association, Charlotte plays a key role in supporting over 600 member organizations. Prior experience includes co-founding New Medicine Partners, leading strategic collaborations across multiple countries, and curating the Cambridge Hub for the World Economic Forum's Global Shapers Network. Charlotte's commitment to empowering innovators is evident from their founding of HealthTech Women’s UK Hub and their leadership in the Hello Tomorrow initiative for healthcare entrepreneurship. Educational accomplishments include an MPhil in Bioscience Enterprise from the University of Cambridge and a Bachelor's in Biomedical Sciences from King's College London.